Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients
BASF to acquire Pronova BioPharma for $842 million
12:05 PM MST | November 28, 2012 | Deepti Ramesh
BASF says it will acquire Pronova BioPharma (Lysaker, Norway), a pioneer in the field of research, development, and manufacturing of omega-3 fatty acids. BASF has reached an agreement with Pronova to make a recommended voluntary public takeover offer to Pronova’s shareholders, and will offer to pay 12.50 Norwegian krone (NK) in cash for each Pronova share. The offer corresponds to a premium of 24% above the average share price for Pronova’s shares in the six months prior to announcement of the public takeover offer, BASF says. Based on all outstanding...
This information is only available to Chemical Week subscribers.
Forgot your user ID or password?
Not an IHS Chemical Week member yet?
Here's why you should be:
100% Satisfaction Guarantee